Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StandingTall is an Australian digital health company/program commercialising a clinically validated home-based exercise platform designed to improve balance, mobility, and confidence and reduce falls in older adults. The product is delivered primarily through a tablet-based app that personalises exercise programs, adapts over time, and can support clinician monitoring through a dashboard. It was developed by falls-prevention and exercise specialists at Neuroscience Research Australia and co-designed with older adults, with product development support from Miroma Project Factory. StandingTall appears to operate as a for-profit health technology venture with enterprise licensing to health and aged-care providers as well as direct-to-consumer access. Its focus is prevention and rehabilitation support rather than drug development, so it has no traditional biopharma pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StandingTall.